Rituximab versus natalizumab, fingolimod, and dimethyl fumarate in multiple sclerosis treatment.

Vollmer BL, Nair K, Sillau S, Corboy JR, Vollmer T, Alvarez E

DOI: 10.1002/acn3.51111
Published: 2020 Sep
Container: Annals of clinical and translational neurology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1002/acn3.51111,
  title = {Rituximab versus natalizumab, fingolimod, and dimethyl fumarate in multiple sclerosis treatment.},
  author = {Vollmer BL and Nair K and Sillau S and Corboy JR and Vollmer T and Alvarez E},
  year = {2020},
  journal = {Annals of clinical and translational neurology},
  doi = {10.1002/acn3.51111},
  url = {https://doi.org/10.1002/acn3.51111}
}

RIS

TY  - JOUR
TI  - Rituximab versus natalizumab, fingolimod, and dimethyl fumarate in multiple sclerosis treatment.
AU  - Vollmer BL
AU  - Nair K
AU  - Sillau S
AU  - Corboy JR
AU  - Vollmer T
AU  - Alvarez E
PY  - 2020
JO  - Annals of clinical and translational neurology
DO  - 10.1002/acn3.51111
UR  - https://doi.org/10.1002/acn3.51111
ER  -

APA

BL, V., K, N., S, S., JR, C., T, V., & E, A. (2020). Rituximab versus natalizumab, fingolimod, and dimethyl fumarate in multiple sclerosis treatment.. Annals of clinical and translational neurology. https://doi.org/10.1002/acn3.51111

Source records

pubmed · retrieved 2026-09-26T14:54:02.777Z